TORONTO, CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN0), a pioneer in the investment, development, and commercialization of cellular agriculture technologies and products, is pleased to announce a partnership with Alcheme Bio to utilize their flavor optimization platform to accelerate development of cellular agriculture products for the Company and its portfolio companies.
Alcheme Bio's proprietary approach utilizes artificial intelligence and machine learning to revolutionize how cultured product companies optimize for flavor and nutrition. Experience targets are determined early in development which significantly reduces R&D time and costs while machine learning is utilized to design the best taste experiences and determine how those tastes should be implemented in development. The outcome is products that consumers love to eat which is vital in ensuring adoption of cultivated meats, dairies and other cell-cultivated foods.
Founded by Vanessa Small, PhD, MBA, who has two decades of scientific experience within organizations such as Pfizer and Abbott, Alcheme Bio is on the leading edge of taste innovation for cellular agriculture. Vanessa was most recently the Head of Biologics at CUE Health and previously developed products for Alere Inc and CalAsia that generated billions of dollars of revenue. She is a Scientific Advisor and Venture Partner for Digital DX Ventures, a venture capital firm focussed on digital healthcare.
Including the Alcheme Bio platform is part of the Company's larger strategy to build out product development infrastructure to accelerate cellular agriculture startups towards market readiness.
Source : Newswire.ca